MA32977B1 - Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol - Google Patents
Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-olInfo
- Publication number
- MA32977B1 MA32977B1 MA34028A MA34028A MA32977B1 MA 32977 B1 MA32977 B1 MA 32977B1 MA 34028 A MA34028 A MA 34028A MA 34028 A MA34028 A MA 34028A MA 32977 B1 MA32977 B1 MA 32977B1
- Authority
- MA
- Morocco
- Prior art keywords
- oxporol
- polymorphic
- aminomethyl
- benzo
- propoxy
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13849008P | 2008-12-17 | 2008-12-17 | |
| PCT/US2009/068609 WO2010080558A1 (en) | 2008-12-17 | 2009-12-17 | Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA32977B1 true MA32977B1 (fr) | 2012-01-02 |
Family
ID=42316734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA34028A MA32977B1 (fr) | 2008-12-17 | 2009-12-17 | Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8461364B2 (https=) |
| EP (1) | EP2378886A4 (https=) |
| JP (1) | JP2012512262A (https=) |
| KR (1) | KR20110111407A (https=) |
| CN (1) | CN102256494A (https=) |
| AU (1) | AU2009335744A1 (https=) |
| BR (1) | BRPI0922566A2 (https=) |
| CA (1) | CA2744231A1 (https=) |
| CO (1) | CO6390029A2 (https=) |
| CR (1) | CR20110357A (https=) |
| DO (1) | DOP2011000183A (https=) |
| EA (1) | EA201190034A1 (https=) |
| IL (1) | IL213060A0 (https=) |
| MA (1) | MA32977B1 (https=) |
| MX (1) | MX2011006334A (https=) |
| PE (1) | PE20120052A1 (https=) |
| SG (1) | SG172040A1 (https=) |
| WO (1) | WO2010080558A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080110984A (ko) | 2005-12-30 | 2008-12-22 | 아나코르 파마슈티칼스 인코포레이티드 | 보론함유 소분자 |
| PT1988779E (pt) | 2006-02-16 | 2015-09-04 | Anacor Pharmaceuticals Inc | Moléculas pequenas contendo boro como agentes antiinflamatórios |
| WO2011094450A1 (en) | 2010-01-27 | 2011-08-04 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules |
| RS60310B1 (sr) | 2010-08-10 | 2020-07-31 | Rempex Pharmaceuticals Inc | Ciklični derivati estra boronske kiseline, postupak za pripremu injihove terapeutske upotrebe |
| SI3251678T1 (sl) * | 2010-09-07 | 2022-01-31 | Anacor Pharmaceuticals, Inc. | Derivati benzoksaborola za zdravljenje bakterijskih okužb |
| JP6031122B2 (ja) * | 2011-12-22 | 2016-11-24 | ミクウルク ファーマシューティカルズ，インコーポレイテッド | 抗微生物療法のための三環式ホウ素化合物 |
| MA38319A1 (fr) | 2013-01-30 | 2016-08-31 | Dow Agrosciences Llc | Utilisation des benzoxaboroles à titre d'agents antimicrobiens volatils sur les viandes, les plantes, ou des parties de plantes |
| US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
| US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
| US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
| US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
| US9598443B2 (en) | 2013-02-01 | 2017-03-21 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules as antiprotozoal agents |
| US20160251380A1 (en) | 2013-08-09 | 2016-09-01 | Glaxosmithkline Intellectual Property (No.2) Limited | Tricyclic benzoxaborole compounds and uses thereof |
| EP3164404B1 (en) | 2014-07-01 | 2019-04-03 | Daiichi Sankyo Company, Limited | Tricyclic benzoxaboroles as antibacterial agents |
| MA41494B1 (fr) | 2015-02-12 | 2020-10-28 | Glaxosmithkline Ip No 2 Ltd | Composés benzoxaborole substitués en position 4 et utilisations associées |
| RS64770B1 (sr) | 2016-03-07 | 2023-11-30 | Agrofresh Inc | Sinergistički postupci upotrebe jedinjenja benzoksaborola i gasova za prezerviranje kao antimikrobnih agenasa za useve |
| MA52337A (fr) | 2017-03-01 | 2021-03-03 | Anacor Pharmaceuticals Inc | Nouveaux analogues d'oxaborole et utilisations de ces derniers |
| EP4204012A1 (en) | 2020-08-31 | 2023-07-05 | Pfizer Inc. | Methods of protecting rna |
| EP4262860A4 (en) | 2020-12-17 | 2025-11-12 | Idexx Lab Inc | DETECTION AND TREATMENT OF ROCKY MOUNTAIN SPRINKLE FEVER |
| EP4384527A4 (en) | 2022-06-23 | 2025-09-03 | Micurx Pharmaceuticals Inc | PRODRUGS OF BORON COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS |
| CN120361018A (zh) * | 2025-05-08 | 2025-07-25 | 扬州大学 | 一种治疗和/或抑制沙门氏菌感染的药物组合物或疫苗和小分子化合物Epetraborole hydrochloride的应用 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2260336A (en) | 1939-10-16 | 1941-10-28 | Dow Chemical Co | Method of preparation of organic borates |
| GB1396904A (en) | 1972-08-11 | 1975-06-11 | Ici Ltd | Method for the control of micro-organisms |
| US4602011A (en) | 1975-10-24 | 1986-07-22 | Chapman Chemical Company | Antimicrobial compositions and methods of using same |
| US4766113A (en) | 1975-10-24 | 1988-08-23 | Chapman Chemical Company | Antimicrobial compositions and methods of using same |
| US4716035A (en) | 1985-05-24 | 1987-12-29 | The Procter & Gamble Company | Oral compositions and methods for treating gingivitis |
| US5962498A (en) | 1986-06-11 | 1999-10-05 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
| US4894220A (en) | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
| SG47101A1 (en) * | 1992-07-31 | 1998-03-20 | Us Bioscience | Crystalline amifostine compositions and methods for the preparation and use of same |
| US5348947A (en) | 1993-05-07 | 1994-09-20 | American Cyanamid Company | Diarylboron ester and thioester fungicidal agents |
| US5348948A (en) | 1993-05-07 | 1994-09-20 | American Cyanamid Company | 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal |
| US5594151A (en) | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
| GB9411587D0 (en) | 1994-06-09 | 1994-08-03 | Zeneca Ltd | Compound, composition and use |
| US6083903A (en) | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| GB9604926D0 (en) | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
| JP4373497B2 (ja) | 1996-06-19 | 2009-11-25 | ローン−プーラン・ロレ・リミテツド | 置換されたアザビシクロ化合物、ならびにｔｎｆおよびサイクリックａｍｐホスホジエステラーゼ産生の阻害剤としてのそれらの使用 |
| US5831046A (en) | 1996-08-05 | 1998-11-03 | Prolinx, Incorporated | Boronic acid-contaning nucleic acid monomers |
| WO1998012206A1 (en) | 1996-09-19 | 1998-03-26 | The Board Of Trustees Of Leland Stanford Jr. University | Dna adenine methyltransferases and uses thereof |
| DE19829947A1 (de) | 1998-07-04 | 2000-01-05 | Bayer Ag | Elektrolumineszierende Anordnungen mit Bor-Chelaten |
| EP1155698A4 (en) | 1999-01-29 | 2003-01-15 | Nitto Kasei Co Ltd | ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY |
| EP1181291A2 (en) | 1999-05-25 | 2002-02-27 | The Penn State Research Foundation | Dna methyltransferase inhibitors |
| US6306628B1 (en) | 1999-08-25 | 2001-10-23 | Ambergen, Incorporated | Methods for the detection, analysis and isolation of Nascent proteins |
| WO2001025226A1 (en) | 1999-10-05 | 2001-04-12 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
| AU7593001A (en) | 2000-07-14 | 2002-01-30 | Zycos Inc | Alpha-msh related compounds and methods of use |
| WO2002044184A2 (en) | 2000-11-30 | 2002-06-06 | The Penn State Research Foundation | Dna methyl transferase inhibitors |
| DE10110051C2 (de) | 2001-03-02 | 2003-07-03 | Clariant Gmbh | Verfahren zur Herstellung von Boron- und Borinsäuren |
| GB0117645D0 (en) | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
| DE10143979A1 (de) | 2001-09-07 | 2003-03-27 | Clariant Gmbh | Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren |
| WO2003033002A1 (en) | 2001-10-11 | 2003-04-24 | Ono Pharmaceutical Co | Intracellular calcium concentration increase inhibitors |
| EP1463739A2 (en) | 2002-01-10 | 2004-10-06 | The Pennsylvania State Research Foundation | Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids |
| EP1980564A1 (en) | 2002-12-18 | 2008-10-15 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
| US7390806B2 (en) | 2002-12-18 | 2008-06-24 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
| US20050125852A1 (en) | 2003-05-09 | 2005-06-09 | Sugen, Inc. | Novel kinases |
| BRPI0411582A (pt) | 2003-06-16 | 2006-08-08 | Anacor Pharmaceuticals Inc | substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso |
| EP1755661B1 (en) | 2004-05-12 | 2014-03-12 | The Brigham And Women's Hospital, Inc. | Gelsolin for use in treating infections |
| US20060111388A1 (en) | 2004-11-19 | 2006-05-25 | University Of North Texas Health Science Center At Fort Worth | Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye |
| GB0501944D0 (en) | 2005-01-31 | 2005-03-09 | Univ Cambridge Tech | Compounds for use in chemical detection and/or quantitation |
| EP2343304B1 (en) | 2005-02-16 | 2015-06-10 | Anacor Pharmaceuticals, Inc. | Biocidal boronophthalide compounds |
| UY29449A1 (es) | 2005-03-30 | 2006-10-02 | Astion Dev As | Tratamiento de enfermedades dermatólogicas y del prurito. |
| WO2007022437A2 (en) | 2005-08-18 | 2007-02-22 | Auspex Pharmaceuticals, Inc. | Therapeutic agents for the treatment of cancer and metabolic disorders |
| KR20080110984A (ko) | 2005-12-30 | 2008-12-22 | 아나코르 파마슈티칼스 인코포레이티드 | 보론함유 소분자 |
| PT1988779E (pt) | 2006-02-16 | 2015-09-04 | Anacor Pharmaceuticals Inc | Moléculas pequenas contendo boro como agentes antiinflamatórios |
| RU2008152367A (ru) | 2006-06-12 | 2010-07-20 | Анакор Фармасьютикалз, Инк. (Us) | Соединения для лечения периодонтального заболевания |
| US20070286822A1 (en) | 2006-06-12 | 2007-12-13 | Anacor Pharmaceuticals Inc. | Compounds for the Treatment of Periodontal Disease |
| JO3396B1 (ar) | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
| KR100895300B1 (ko) | 2007-07-20 | 2009-05-07 | 한국전자통신연구원 | 생체신호 측정의복과 생체신호 처리시스템 |
| WO2009111676A2 (en) | 2008-03-06 | 2009-09-11 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules as anti-inflammatory agents |
| EP2285384A4 (en) | 2008-05-12 | 2012-04-25 | Anacor Pharmaceuticals Inc | BORN SMALL MOLECULES |
| WO2010028005A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
| WO2010045503A1 (en) | 2008-10-15 | 2010-04-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
| WO2010045505A1 (en) | 2008-10-15 | 2010-04-22 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules as anti-protozoal agents |
-
2009
- 2009-12-17 WO PCT/US2009/068609 patent/WO2010080558A1/en not_active Ceased
- 2009-12-17 US US12/641,318 patent/US8461364B2/en not_active Expired - Fee Related
- 2009-12-17 BR BRPI0922566A patent/BRPI0922566A2/pt not_active IP Right Cessation
- 2009-12-17 MX MX2011006334A patent/MX2011006334A/es not_active Application Discontinuation
- 2009-12-17 KR KR1020117016565A patent/KR20110111407A/ko not_active Withdrawn
- 2009-12-17 CN CN2009801506662A patent/CN102256494A/zh active Pending
- 2009-12-17 MA MA34028A patent/MA32977B1/fr unknown
- 2009-12-17 EP EP09837955A patent/EP2378886A4/en not_active Withdrawn
- 2009-12-17 CA CA2744231A patent/CA2744231A1/en not_active Abandoned
- 2009-12-17 EA EA201190034A patent/EA201190034A1/ru unknown
- 2009-12-17 AU AU2009335744A patent/AU2009335744A1/en not_active Abandoned
- 2009-12-17 JP JP2011542458A patent/JP2012512262A/ja active Pending
- 2009-12-17 PE PE2011001246A patent/PE20120052A1/es not_active Application Discontinuation
- 2009-12-17 SG SG2011041894A patent/SG172040A1/en unknown
-
2011
- 2011-05-23 IL IL213060A patent/IL213060A0/en unknown
- 2011-06-09 CO CO11071901A patent/CO6390029A2/es not_active Application Discontinuation
- 2011-06-13 DO DO2011000183A patent/DOP2011000183A/es unknown
- 2011-06-23 CR CR20110357A patent/CR20110357A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO6390029A2 (es) | 2012-02-29 |
| SG172040A1 (en) | 2011-07-28 |
| PE20120052A1 (es) | 2012-02-13 |
| IL213060A0 (en) | 2011-07-31 |
| KR20110111407A (ko) | 2011-10-11 |
| CA2744231A1 (en) | 2010-07-15 |
| EP2378886A1 (en) | 2011-10-26 |
| EP2378886A4 (en) | 2012-08-29 |
| JP2012512262A (ja) | 2012-05-31 |
| DOP2011000183A (es) | 2011-07-15 |
| CN102256494A (zh) | 2011-11-23 |
| MX2011006334A (es) | 2011-09-22 |
| WO2010080558A1 (en) | 2010-07-15 |
| US8461364B2 (en) | 2013-06-11 |
| AU2009335744A1 (en) | 2010-07-15 |
| CR20110357A (es) | 2011-11-11 |
| US20110152217A1 (en) | 2011-06-23 |
| EA201190034A1 (ru) | 2012-02-28 |
| BRPI0922566A2 (pt) | 2017-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA32977B1 (fr) | Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol | |
| SMT201400142B (it) | Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms | |
| ZA200710172B (en) | Cyclic amine derivative having substituted alkyl group | |
| EA201200741A1 (ru) | Способ получения этексилата дабигатрана | |
| CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
| MA35452B1 (fr) | 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante | |
| CO6852084A2 (es) | Nuevos compuestos sustituidos con halógeno | |
| BRPI0914772A2 (pt) | compostos heterocíclicos 1,2-dissubstituídos | |
| CY1112705T1 (el) | Συντηγμενες κυκλικες ενωσεις | |
| EP2481725A4 (en) | SUBSTITUTED AMID CONNECTION | |
| EA201170872A1 (ru) | Ингибиторы протеинкиназы | |
| EP2677562A3 (en) | Arylamines for organic electroluminescent devices | |
| EP2199282A4 (en) | amide | |
| CY1112722T1 (el) | Μυκητοκτονες συνθεσεις | |
| SI2344465T1 (sl) | Kristaliniäśne oblike (r)-5-(3-kloro-4-(2,3-dihidroksi-propoksi)- benz(z)iliden)-2-(z)-propilimino)-3-o-tolil-tiazolidin-4-ona | |
| EA201270216A1 (ru) | Фармацевтический состав | |
| DK2010496T3 (da) | 4-anilinoquinolin-3-carbonsyreamider som CSF-1R-kinaseinhibitorer | |
| MY150778A (en) | Fused heterocyclic compound | |
| EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
| ITBO20060719A1 (it) | Macchina per la produzione di filtri composti. | |
| MX2011006095A (es) | Dihidroetorfina y su preparacion. | |
| SI2132204T1 (sl) | Kristalinične oblike 8-azabiciklo(3.2.1) oktanske spojine | |
| CR20140114A (es) | Compuestos de benzotiazolona | |
| EA201170721A1 (ru) | 3-аминоциклопентанкарбоксамиды в качестве модуляторов рецептора хемокина | |
| ITBO20060720A1 (it) | Macchina per la produzione di filtri composti. |